期刊文献+

花生四烯酸代谢网络研究:从关键酶的单靶标抑制剂到多靶标抑制剂 被引量:26

Controlling arachidonic acid metabolic network: from single-to multi-target inhibitors of key enzymes
原文传递
导出
摘要 炎症引发的疾病是人类常见的免疫系统疾病,医药市场对抗炎药物的需求量极大。花生四烯酸代谢网络是产生炎症介质的主要网络,网络中的一些蛋白质已成为抗炎药物设计的重要靶标,但这些单靶标药物不能很好地控制网络的平衡,同时容易引起副作用。大多数炎症引发的疾病是由多级联炎症代谢共同影响的结果,为了更好地治疗这类由多个药靶参与调控的复杂疾病,发展针对花生四烯酸代谢网络的多靶标药物具有迫切性。本文综述花生四烯酸代谢网络的关键靶标(如磷脂酶A2、环氧合酶、5-脂氧合酶和白三烯A4水解酶等)的特异性抑制剂和多靶标抑制剂研究进展。 Inflammatory diseases are common medical conditions seen in disorders of human immune system. There is a great demand for anti-inflammatory drugs. There are major inflammatory mediators in arachidonic acid metabolic network. Several enzymes in this network have been used as key targets for the development of anti-inflammatory drugs. However, specific single-target inhibitors can not sufficiently control the network balance and may cause side effects at the same time. Most inflammation induced diseases come from the complicated coupling of inflammatory cascades involving multiple targets. In order to treat these complicated diseases, drugs that can intervene multi-targets at the same time attracted much attention. The goal of this review is mainly focused on the key enzymes in arachidonic acid metabolic network, such as phospholipase A2, cyclooxygenase, 5-lipoxygenase and eukotriene A4 hydrolase. Advance in single target and multi-targe inhibitors is summarized.
出处 《药学学报》 CAS CSCD 北大核心 2009年第3期231-241,共11页 Acta Pharmaceutica Sinica
基金 国家自然科学基金资助项目(20773002,20873003)
关键词 花生四烯酸代谢网络 关键酶 单靶标抑制剂 多靶标抑制剂 arachidonic acid metabolic network key enzymes single-target inhibitors multi-target inhibitors
  • 相关文献

参考文献64

  • 1Bolognesi M, Minarini A, Rosini M, et al. From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): a step forward in the treatment of Alzheimer's disease [J]. Mini Rev Med Chem, 2008, 8: 960-967.
  • 2Bolognesi ML, Banzi R, Bartolini M, et al. Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease [J]. J Med Chem, 2007, 50: 4882-4897.
  • 3Chen CH, Liu DZ, Fang HW, et al. Evaluation Of multi-target and single-target liposomal drugs for the treatment of gastric cancer [J]. Biosci Biotechnol Biochem, 2008, 72: 1586- 1594.
  • 4Petrelli A, Giordano S. From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage [J]. Curr Med Chem, 2008, 15: 422-432.
  • 5Wong EH, Nikam SS, Shahid M. Multi- and single-target agents for major psychiatric diseases: therapeutic opportunities and challenges [J]. Curr Opin Investig Drugs, 2008, 9: 28-36.
  • 6Korcsmaros T, Szalay M, Bode C, et al. How to design multi-target drugs: target search options in cellular networks [J]. Invited Review to Expert Opinion on Drug Discovery, 2007, 2: 1-10.
  • 7Csermely P, Agoston V, Pongor S. The efficiency of multitarget drugs: the network approach might help drug design [J]. Trends Pharmacol Sci, 2005, 26: 178-182.
  • 8Morphy R, Rankovic Z. Fragments, network biology and designing multiple ligands [J]. Drug Discov Today, 2007, 12: 156-160.
  • 9Meyer MC, Rastogi P, Beckett CS, et al. Phospholipase A(2) inhibitors as potential anti-inflammatory agents [J]. Curr Pharm Des, 2005, 11: 1301-1312.
  • 10Serhan CN. Preventing injury from within, using selective cPLA2 inhibitors [J]. Nat Immunol, 2000, 1: 13-15.

同被引文献280

引证文献26

二级引证文献174

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部